- Date of the board of directors resolution: Mar 09, 2018
- Date for convening the shareholders’ meeting: Jun 27, 2018
- Location for convening the shareholders’ meeting: Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Da’ an Dist., Taipei City, Taiwan)
- Cause or subjects for convening the meeting (1)Report Items:
<1> 2017 Business Results
<2> 2017 Audit Committee’s Review Report
<3> Comprehensive business initiatives
<4> Revision on the Code of Integrity
<5> Revision on the Integrity Management Procedures and Conduct Guideline - Cause or subjects for convening the meeting (2)Matters for Ratification:
<1> 2017 Settlement Statements
<2> 2017 Deficit Compensation - Cause or subjects for convening the meeting (3)Matters for Discussion: None
- Cause or subjects for convening the meeting (4)Elections: None
- Cause or subjects for convening the meeting (5)Other Proposals: None
- Cause or subjects for convening the meeting (6)Extemporary Motions: None
- Book closure starting date: Apr 29, 2018
- Book closure ending date: Jun 27, 2018
- Any other matters that need to be specified:
Pursuant to Article 172-1 of the Company Law, the Annual General Meeting will accept shareholders’ proposals from Apr 20, 2018 to Apr 30, 2018. Shareholders holding more than 1% of shares should deliver proposal with applicable contact information before 5:00pm on Apr 30 for the board of directors to review and respond. (Please note the Annual General Meeting on the envelope and send it by priority mail). Overdue will not be accepted.
Proposal receiving office is the Financial Department of OBI Pharma Inc. (Address: 7th Floor, No. 369, Section 7, Zhongxiao East Road, Nangang District, Taipei, Tel: 02-27866589, ext. 115/157). The shareholders will be able to exercise their voting rights electronically from May 28, 2018 to Jun 24, 2018. The electronic voting system is managed by Taiwan Depository and Clearing Corporation at https://www.stockvote.com.tw